Method for treating the endotoxic shock in mammals
US6429188B1 · kind B1 · utility
15Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2000 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | Apr 3, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method for the treatment of endotoxic shock in mammals. The use of vasoactive intestinal peptide (VIP) and peptide activating hypofissiary adenylate cyclase (PACAP) is described in the treatment of endotoxic shock in mammals. These substances inhibit the production of tumor necrosis factor (TNF) and interleukin 6 (IL-6).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.